Brain MRI Findings in Pediatric-Onset Neuromyelitis Optica Spectrum Disorder: Challenges in Differentiation from Acute Disseminated Encephalomyelitis

REFERENCES

1. 1.↵
   2. Wingerchuk DM,
   3. Hogancamp WF,
   4. O'Brien PC, et al

   . The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107–14 doi:10.1212/WNL.53.5.1107 pmid:10496275

   Abstract/FREE Full Text
2. 2.↵
   2. Wingerchuk DM,
   3. Lennon VA,
   4. Pittock SJ, et al

   . Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485–89 doi:10.1212/01.wnl.0000216139.44259.74 pmid:16717206

   Abstract/FREE Full Text
3. 3.↵
   2. Wingerchuk DM,
   3. Lennon VA,
   4. Lucchinetti CF, et al

   . The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805–15 doi:10.1016/S1474-4422(07)70216-8 pmid:17706564

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Wingerchuk DM,
   3. Banwell B,
   4. Bennett JL, et al

   ; International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177–89 doi:10.1212/WNL.0000000000001729 pmid:26092914

   CrossRefPubMed
5. 5.↵
   2. Pittock SJ,
   3. Lennon VA,
   4. Krecke K, et al

   . Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390–96 doi:10.1001/archneur.63.3.390 pmid:16533966

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Pittock SJ,
   3. Weinshenker BG,
   4. Lucchinetti CF, et al

   . Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006;63:964–68 doi:10.1001/archneur.63.7.964 pmid:16831965

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Kim W,
   3. Park MS,
   4. Lee SH, et al

   . Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler 2010;16:1229–36 doi:10.1177/1352458510376640 pmid:20685766

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Kim HJ,
   3. Paul F,
   4. Lana-Peixoto MA, et al

   ; Guthy-Jackson Charitable Foundation NMO International Clinical Consortium & Biorepository. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 2015;84:1165–73 doi:10.1212/WNL.0000000000001367 pmid:25695963

   Abstract/FREE Full Text
9. 9.↵
   2. Katz Sand I

   . Neuromyelitis optica spectrum disorders. Continuum (Minneap Minn) 2016;22:864–96 doi:10.1212/CON.0000000000000337 pmid:27261687

   CrossRefPubMed
10. 10.↵
    2. Kim JE,
    3. Kim SM,
    4. Ahn SW, et al

    . Brain abnormalities in neuromyelitis optica. J Neurol Sci 2011;302:43–48 doi:10.1016/j.jns.2010.12.001 pmid:21236446

    CrossRefPubMed
11. 11.↵
    2. Tenembaum S,
    3. Chitnis T,
    4. Nakashima I, et al

    . Neuromyelitis optica spectrum disorders in children and adolescents. Neurology 2016;87:S59–66 doi:10.1212/WNL.0000000000002824 pmid:27572863

    Abstract/FREE Full Text
12. 12.↵
    2. McKeon A,
    3. Lennon VA,
    4. Lotze T, et al

    . CNS aquaporin-4 autoimmunity in children. Neurology 2008;71:93–100 doi:10.1212/01.wnl.0000314832.24682.c6 pmid:18509092

    Abstract/FREE Full Text
13. 13.↵
    2. Absoud M,
    3. Lim MJ,
    4. Appleton R, et al

    . Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features. J Neurol Neurosurg Psychiatry 2015;86:470–72 doi:10.1136/jnnp-2014-308550 pmid:25091363

    Abstract/FREE Full Text
14. 14.↵
    2. Collongues N,
    3. Marignier R,
    4. Zéphir H, et al

    . Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology 2010;75:1084–88 doi:10.1212/WNL.0b013e3181f39a66 pmid:20855851

    Abstract/FREE Full Text
15. 15.↵
    2. Rostasy K,
    3. Bajer-Kornek B,
    4. Venkateswaran S, et al

    . Differential diagnosis and evaluation in pediatric inflammatory demyelinating disorders. Neurology 2016;87:S28–37 doi:10.1212/WNL.0000000000002878 pmid:27572858

    Abstract/FREE Full Text
16. 16.↵
    2. Kim W,
    3. Kim SH,
    4. Lee SH, et al

    . Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler 2011;17:1107–12 doi:10.1177/1352458511404917 pmid:21543554

    CrossRefPubMed
17. 17.↵
    2. Wingerchuk DM,
    3. Weinshenker BG

    . Neuromyelitis optica. Curr Treat Options Neurol 2008;10:55–66 doi:10.1007/s11940-008-0007-z pmid:18325300

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Lotze TE,
    3. Northrop JL,
    4. Hutton GJ, et al

    . Spectrum of pediatric neuromyelitis optica. Pediatrics 2008;122:e1039–47 doi:10.1542/peds.2007-2758 pmid:18838462

    Abstract/FREE Full Text
19. 19.↵
    2. Matsushita T,
    3. Isobe N,
    4. Matsuoka T, et al

    . Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions. Mult Scler 2009;15:1113–17 doi:10.1177/1352458509106613 pmid:19625334

    CrossRefPubMed
20. 20.↵
    2. Banwell B,
    3. Tenembaum S,
    4. Lennon VA, et al

    . Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008;70:344–52 doi:10.1212/01.wnl.0000284600.80782.d5 pmid:18094334

    Abstract/FREE Full Text
21. 21.↵
    2. Kremer L,
    3. Mealy M,
    4. Jacob A, et al

    . Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients. Mult Scler 2014;20:843–47 doi:10.1177/1352458513507822 pmid:24099751

    CrossRefPubMed
22. 22.↵
    2. Peña JA,
    3. Ravelo ME,
    4. Mora-La Cruz E, et al

    . NMO in pediatric patients: brain involvement and clinical expression. Arq Neuropsiquiatr 2011;69:34–38 doi:10.1590/S0004-282X2011000100008 pmid:21359420

    CrossRefPubMed
23. 23.↵
    2. Marin SE,
    3. Callen DJ

    . The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria. Neuroimaging Clin N Am 2013;23:245–66 doi:10.1016/j.nic.2012.12.005 pmid:23608688

    CrossRefPubMed
24. 24.↵
    2. Orman G,
    3. Wang KY,
    4. Pekcevik Y, et al

    . Enhancing brain lesions during acute optic neuritis and/or longitudinally extensive transverse myelitis may portend a higher relapse rate in neuromyelitis optica spectrum disorders. AJNR Am J Neuroradiol 2017;38:949–53 doi:10.3174/ajnr.A5141 pmid:28302609

    Abstract/FREE Full Text
25. 25.↵
    2. Ito S,
    3. Mori M,
    4. Makino T, et al

    . “Cloud-like enhancement” is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009;66:425–28 doi:10.1002/ana.21753 pmid:19798642

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Banker P,
    3. Sonni S,
    4. Kister I, et al

    . Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders. Mult Scler 2012;18:1050–53 doi:10.1177/1352458511431730 pmid:22183933

    CrossRefPubMed
27. 27.↵
    2. Long Y,
    3. Chen M,
    4. Zhang B, et al

    . Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid. J Neuroimmunol 2014;269:62–67 doi:10.1016/j.jneuroim.2014.02.006 pmid:24582827

    CrossRefPubMed
28. 28.↵
    2. Pekcevik Y,
    3. Izbudak I

    . Perivascular enhancement in a patient with neuromyelitis optica spectrum disease during an optic neuritis attack. J Neuroimaging 2015;25:686–87 doi:10.1111/jon.12198 pmid:25496413

    CrossRefPubMed
29. 29.↵
    2. Saiki S,
    3. Ueno Y,
    4. Moritani T, et al

    . Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica. J Neurol Sci 2009;284:217–19 doi:10.1016/j.jns.2009.05.022 pmid:19497587

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Zuccoli G,
    3. Panigrahy A,
    4. Sreedher G, et al

    . Vasogenic edema characterizes pediatric acute disseminated encephalomyelitis. Neuroradiology 2014;56:679–84 doi:10.1007/s00234-014-1379-2 pmid:24854347

    CrossRefPubMed
31. 31.↵
    2. Narayan R,
    3. Simpson A,
    4. Fritsche K, et al

    . MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 2018;25:66–72 doi:10.1016/j.msard.2018.07.025 pmid:30048919

    CrossRefPubMed